Skip to main content
main-content
Erschienen in: Endocrine 2/2022

25.06.2022 | Original Article

Adipokines and coronary artery calcification in incident dialysis participants

verfasst von: Neil Roy, Danny Haddad, Wei Yang, Sylvia E. Rosas

Erschienen in: Endocrine | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Adipokines have been associated with increased risk of cardiovascular disease. Our aim was to determine if adipokine levels are associated with coronary artery calcification (CAC) as well as all-cause mortality in incident dialysis patients.

Methods

In patients new to dialysis, we prospectively investigated the association of adiponectin, leptin and resistin with coronary artery calcification measured by ECG-gated computer tomography. Participants were recruited a median of two months after starting dialysis.

Results

The mean age was 50.0 (12.6) years and 31.1% were women. About 42% percent had BMI > 30. Higher adiponectin levels were inversely associated with CAC progression as change in Agatston score [−155.1 (−267.9, −42.2), p = 0.008] or change in CAC volumes between scans [−2.8 (−4.9, −0.6), p = 0.01]. Higher leptin levels were associated with CAC progression [110.4 (34.3–186.6), p = 0.005]. Decreased leptin [HR 0.5 (0.3–0.9), p = 0.05] was associated with all-cause mortality in adjusted models. There was no significant association between all-cause mortality and adiponectin [1.4 (0.6–3.4), p = 0.4] or resistin [HR 1.7 (0.5–5.0), p = 0.4].

Conclusion

High adiponectin protects against CAC progression, but is not associated with increased all-cause mortality. Higher leptin, as well as higher leptin to adiponectin ratio, is associated with CAC progression. Lower leptin levels were associated with all-cause mortality. The association of adipokines and cardiovascular disease in individuals on dialysis is complex and requires further study.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat S.E. Rosas et al. Coronary artery calcification in renal transplant recipients. Am. J. Transpl. 5(8), 1942–1947 (2005) CrossRef S.E. Rosas et al. Coronary artery calcification in renal transplant recipients. Am. J. Transpl. 5(8), 1942–1947 (2005) CrossRef
2.
Zurück zum Zitat A.M. Khan et al. FGF-23 and the progression of coronary arterial calcification in patients new to dialysis. Clin. J. Am. Soc. Nephrol. 7(12), 2017–2022 (2012) PubMedPubMedCentralCrossRef A.M. Khan et al. FGF-23 and the progression of coronary arterial calcification in patients new to dialysis. Clin. J. Am. Soc. Nephrol. 7(12), 2017–2022 (2012) PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat H.J. Kramer et al. Increasing body mass index and obesity in the incident ESRD population. J. Am. Soc. Nephrol. 17(5), 1453–1459 (2006) PubMedCrossRef H.J. Kramer et al. Increasing body mass index and obesity in the incident ESRD population. J. Am. Soc. Nephrol. 17(5), 1453–1459 (2006) PubMedCrossRef
4.
Zurück zum Zitat J.F. Briffa et al. Adipokines as a link between obesity and chronic kidney disease. Am. J. Physiol. Ren. Physiol. 305(12), F1629–F1636 (2013) CrossRef J.F. Briffa et al. Adipokines as a link between obesity and chronic kidney disease. Am. J. Physiol. Ren. Physiol. 305(12), F1629–F1636 (2013) CrossRef
5.
Zurück zum Zitat T. Yamauchi et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7(8), 941–946 (2001). PubMedCrossRef T. Yamauchi et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7(8), 941–946 (2001). PubMedCrossRef
6.
Zurück zum Zitat A. Wiecek, M. Adamczak, J. Chudek, Adiponectin–an adipokine with unique metabolic properties. Nephrol. Dial. Transpl. 22(4), 981–988 (2007) CrossRef A. Wiecek, M. Adamczak, J. Chudek, Adiponectin–an adipokine with unique metabolic properties. Nephrol. Dial. Transpl. 22(4), 981–988 (2007) CrossRef
7.
Zurück zum Zitat X.H. Luo et al. Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification. J. Bone Min. Res. 24(8), 1461–1468 (2009) CrossRef X.H. Luo et al. Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification. J. Bone Min. Res. 24(8), 1461–1468 (2009) CrossRef
8.
Zurück zum Zitat D.M. Maahs et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111(6), 747–753 (2005) PubMedCrossRef D.M. Maahs et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111(6), 747–753 (2005) PubMedCrossRef
9.
Zurück zum Zitat M.B. Schulze et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 54(2), 534–539 (2005) PubMedCrossRef M.B. Schulze et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 54(2), 534–539 (2005) PubMedCrossRef
10.
Zurück zum Zitat M. Ai et al. Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study. Atherosclerosis 217(2), 543–548 (2011) PubMedPubMedCentralCrossRef M. Ai et al. Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study. Atherosclerosis 217(2), 543–548 (2011) PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat K. Sharma et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int. 51(6), 1980–1985 (1997) PubMedCrossRef K. Sharma et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int. 51(6), 1980–1985 (1997) PubMedCrossRef
12.
Zurück zum Zitat M. Zeadin et al. Effect of leptin on vascular calcification in apolipoprotein E-deficient mice. Arterioscler Thromb. Vasc. Biol. 29(12), 2069–2075 (2009) PubMedCrossRef M. Zeadin et al. Effect of leptin on vascular calcification in apolipoprotein E-deficient mice. Arterioscler Thromb. Vasc. Biol. 29(12), 2069–2075 (2009) PubMedCrossRef
13.
Zurück zum Zitat E.L. Scheller et al. Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells 28(6), 1071–1080 (2010) PubMedPubMedCentralCrossRef E.L. Scheller et al. Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells 28(6), 1071–1080 (2010) PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat A. Scholze et al. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obes. (Silver Spring) 15(6), 1617–1622 (2007) CrossRef A. Scholze et al. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obes. (Silver Spring) 15(6), 1617–1622 (2007) CrossRef
15.
Zurück zum Zitat F. Mallamaci, G. Tripepi, C. Zoccali, Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system. J. Nephrol. 18(4), 464–468 (2005) PubMed F. Mallamaci, G. Tripepi, C. Zoccali, Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system. J. Nephrol. 18(4), 464–468 (2005) PubMed
16.
Zurück zum Zitat R. Kawamura et al. Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study. Nephrol. Dial. Transpl. 25(10), 3236–3240 (2010) CrossRef R. Kawamura et al. Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study. Nephrol. Dial. Transpl. 25(10), 3236–3240 (2010) CrossRef
17.
Zurück zum Zitat S. Verma et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108(6), 736–740 (2003) PubMedCrossRef S. Verma et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108(6), 736–740 (2003) PubMedCrossRef
18.
Zurück zum Zitat A. Kunnari et al. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J. Clin. Endocrinol. Metab. 91(7), 2755–2760 (2006) PubMedCrossRef A. Kunnari et al. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J. Clin. Endocrinol. Metab. 91(7), 2755–2760 (2006) PubMedCrossRef
19.
Zurück zum Zitat A.S. Agatston et al. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15(4), 827–832 (1990) PubMedCrossRef A.S. Agatston et al. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15(4), 827–832 (1990) PubMedCrossRef
20.
Zurück zum Zitat J.E. Hokanson et al. Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am. J. Roentgenol. 182(5), 1327–1332 (2004) PubMedCrossRef J.E. Hokanson et al. Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am. J. Roentgenol. 182(5), 1327–1332 (2004) PubMedCrossRef
21.
Zurück zum Zitat T. Kazumi et al. Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men. Metabolism 53(5), 589–593 (2004) PubMedCrossRef T. Kazumi et al. Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men. Metabolism 53(5), 589–593 (2004) PubMedCrossRef
22.
Zurück zum Zitat C. Zoccali et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 13(1), 134–141 (2002) PubMedCrossRef C. Zoccali et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 13(1), 134–141 (2002) PubMedCrossRef
23.
Zurück zum Zitat M. Rao et al. Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol. Dial. Transpl. 23(8), 2619–2628 (2008) CrossRef M. Rao et al. Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol. Dial. Transpl. 23(8), 2619–2628 (2008) CrossRef
24.
Zurück zum Zitat J.J. Diez et al. High stable serum adiponectin levels are associated with a better outcome in prevalent dialysis patients. Am. J. Nephrol. 30(3), 244–252 (2009) PubMedCrossRef J.J. Diez et al. High stable serum adiponectin levels are associated with a better outcome in prevalent dialysis patients. Am. J. Nephrol. 30(3), 244–252 (2009) PubMedCrossRef
25.
Zurück zum Zitat F. Takemoto et al. Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients–a Japanese prospective eight-year study. Nephron Clin. Pr. 111(1), c12–c20 (2009) CrossRef F. Takemoto et al. Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients–a Japanese prospective eight-year study. Nephron Clin. Pr. 111(1), c12–c20 (2009) CrossRef
26.
Zurück zum Zitat T. Sakura et al. The association of serum adiponectin with abdominal aortic calcification in Japanese male hemodialysis patients: a cross-sectional observational study. Sci. Rep. 7(1), 6434 (2017) PubMedPubMedCentralCrossRef T. Sakura et al. The association of serum adiponectin with abdominal aortic calcification in Japanese male hemodialysis patients: a cross-sectional observational study. Sci. Rep. 7(1), 6434 (2017) PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat B.A. Larsen et al. Adipokines and severity and progression of coronary artery calcium: findings from the Rancho Bernardo Study. Atherosclerosis 265, 1–6 (2017) PubMedPubMedCentralCrossRef B.A. Larsen et al. Adipokines and severity and progression of coronary artery calcium: findings from the Rancho Bernardo Study. Atherosclerosis 265, 1–6 (2017) PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Anubhuti, S. Arora, Leptin and its metabolic interactions: an update. Diabetes Obes. Metab. 10(11), 973–993 (2008) PubMedCrossRef Anubhuti, S. Arora, Leptin and its metabolic interactions: an update. Diabetes Obes. Metab. 10(11), 973–993 (2008) PubMedCrossRef
29.
30.
Zurück zum Zitat A. Rahmani et al. Association between plasma leptin/adiponectin ratios with the extent and severity of coronary artery disease. BMC Cardiovasc Disord. 20(1), 474 (2020) PubMedPubMedCentralCrossRef A. Rahmani et al. Association between plasma leptin/adiponectin ratios with the extent and severity of coronary artery disease. BMC Cardiovasc Disord. 20(1), 474 (2020) PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat M.C. Lee et al. Serum leptin levels positively correlate with peripheral arterial stiffness in kidney transplantation patients. Transpl. Proc. 46(2), 353–358 (2014) CrossRef M.C. Lee et al. Serum leptin levels positively correlate with peripheral arterial stiffness in kidney transplantation patients. Transpl. Proc. 46(2), 353–358 (2014) CrossRef
32.
Zurück zum Zitat P. Szulc et al. Positive association of high leptin level and abdominal aortic calcification in men- the prospective MINOS study. Circ. J. 82(12), 2954–2961 (2018) PubMedCrossRef P. Szulc et al. Positive association of high leptin level and abdominal aortic calcification in men- the prospective MINOS study. Circ. J. 82(12), 2954–2961 (2018) PubMedCrossRef
34.
Zurück zum Zitat M.P. Reilly et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J. Clin. Endocrinol. Metab. 89(8), 3872–3878 (2004) PubMedCrossRef M.P. Reilly et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J. Clin. Endocrinol. Metab. 89(8), 3872–3878 (2004) PubMedCrossRef
35.
Zurück zum Zitat C. Iribarren et al. Plasma leptin levels and coronary artery calcification in older adults. J. Clin. Endocrinol. Metab. 92(2), 729–732 (2007) PubMedCrossRef C. Iribarren et al. Plasma leptin levels and coronary artery calcification in older adults. J. Clin. Endocrinol. Metab. 92(2), 729–732 (2007) PubMedCrossRef
36.
Zurück zum Zitat B. Varma, et al. Higher leptin levels are associated with coronary artery calcium progression: the multi-ethnic study of atherosclerosis (MESA).Diabet. Epidemiol. Manag. 6, 100047 (2022) PubMedCrossRef B. Varma, et al. Higher leptin levels are associated with coronary artery calcium progression: the multi-ethnic study of atherosclerosis (MESA).Diabet. Epidemiol. Manag. 6, 100047 (2022) PubMedCrossRef
37.
Zurück zum Zitat C. Aoqui et al. Increased visceral adiposity is associated with coronary artery calcification in male patients with chronic kidney disease. Eur. J. Clin. Nutr. 67(6), 610–614 (2013) PubMedCrossRef C. Aoqui et al. Increased visceral adiposity is associated with coronary artery calcification in male patients with chronic kidney disease. Eur. J. Clin. Nutr. 67(6), 610–614 (2013) PubMedCrossRef
38.
Zurück zum Zitat S.G. Wannamethee et al. The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin. Int. J. Cardiol. 171(1), 49–55 (2014) PubMedPubMedCentralCrossRef S.G. Wannamethee et al. The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin. Int. J. Cardiol. 171(1), 49–55 (2014) PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat X. Bian et al. Association of leptin with mortality in patients on maintenance hemodialysis: a prospective study. Iran. J. Kidney Dis. 8(4), 314–320 (2014) PubMed X. Bian et al. Association of leptin with mortality in patients on maintenance hemodialysis: a prospective study. Iran. J. Kidney Dis. 8(4), 314–320 (2014) PubMed
41.
Zurück zum Zitat A. Scholze, M. Tepel, Role of leptin in reverse epidemiology in chronic kidney disease. Semin Dial. 20(6), 534–538 (2007) PubMedCrossRef A. Scholze, M. Tepel, Role of leptin in reverse epidemiology in chronic kidney disease. Semin Dial. 20(6), 534–538 (2007) PubMedCrossRef
42.
Zurück zum Zitat M. Freemark, Metabolomics in nutrition research: biomarkers predicting mortality in children with severe acute malnutrition. Food Nutr. Bull. 36(1 Suppl), S88–S92 (2015) PubMedCrossRef M. Freemark, Metabolomics in nutrition research: biomarkers predicting mortality in children with severe acute malnutrition. Food Nutr. Bull. 36(1 Suppl), S88–S92 (2015) PubMedCrossRef
43.
Zurück zum Zitat J.M. Njunge et al. Biomarkers of post-discharge mortality among children with complicated severe acute malnutrition. Sci. Rep. 9(1), 5981 (2019) PubMedPubMedCentralCrossRef J.M. Njunge et al. Biomarkers of post-discharge mortality among children with complicated severe acute malnutrition. Sci. Rep. 9(1), 5981 (2019) PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat G.M. Lord et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696), 897–901 (1998) PubMedCrossRef G.M. Lord et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696), 897–901 (1998) PubMedCrossRef
45.
Zurück zum Zitat R. Faggioni et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am. J. Physiol. 276(1), R136–R142 (1999) PubMedCrossRef R. Faggioni et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am. J. Physiol. 276(1), R136–R142 (1999) PubMedCrossRef
46.
Zurück zum Zitat G.S. Filippatos et al. Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system. Int J. Cardiol. 76(2–3), 117–122 (2000) PubMedCrossRef G.S. Filippatos et al. Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system. Int J. Cardiol. 76(2–3), 117–122 (2000) PubMedCrossRef
47.
Zurück zum Zitat W. Wulaningsih et al. Serum leptin, C-reactive protein, and cancer mortality in the NHANES III. Cancer Med 5(1), 120–128 (2016) PubMedCrossRef W. Wulaningsih et al. Serum leptin, C-reactive protein, and cancer mortality in the NHANES III. Cancer Med 5(1), 120–128 (2016) PubMedCrossRef
48.
Zurück zum Zitat M.P. Reilly et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111(7), 932–939 (2005) PubMedCrossRef M.P. Reilly et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111(7), 932–939 (2005) PubMedCrossRef
49.
Zurück zum Zitat C.M. Steppan et al. The hormone resistin links obesity to diabetes. Nature 409(6818), 307–312 (2001) PubMedCrossRef C.M. Steppan et al. The hormone resistin links obesity to diabetes. Nature 409(6818), 307–312 (2001) PubMedCrossRef
50.
Zurück zum Zitat J. Axelsson et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 69(3), 596–604 (2006) PubMedCrossRef J. Axelsson et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 69(3), 596–604 (2006) PubMedCrossRef
51.
Zurück zum Zitat K.M. Utzschneider et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 48(11), 2330–2333 (2005) PubMedCrossRef K.M. Utzschneider et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 48(11), 2330–2333 (2005) PubMedCrossRef
Metadaten
Titel
Adipokines and coronary artery calcification in incident dialysis participants
verfasst von
Neil Roy
Danny Haddad
Wei Yang
Sylvia E. Rosas
Publikationsdatum
25.06.2022
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2022
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03111-x

Weitere Artikel der Ausgabe 2/2022

Endocrine 2/2022 Zur Ausgabe

Neu im Fachgebiet Innere Medizin

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.